The KRAS downstream signaling pathways include the MAP-kinases (MAPK), the PI3-kinase (PI3K)/AKT/mTOR pathway, and the small GTPases Rho, Rac, and Ral driving proliferation, survival, metabolic adaptions, and tumor growth. This evidence concerns the gene KRAS and neoplasm.